The New Era of Weight Loss Injections in the UK: Understanding Mounjaro and Wegovy

Advances in the understanding of appetite hormones have led to medicines designed to influence the biological signals involved in hunger and fullness. Among the most widely recognised treatments are Mounjaro and Wegovy.

Both are prescription treatments used as part of medically supported weight management, but their mechanisms are different. Understanding those differences can help explain why treatment needs to be personalised.

Why Appetite Hormones Matter

Hunger is influenced by far more than motivation or willpower.

The digestive system and brain communicate through a complex network of hormones that affect appetite, fullness and food intake.

GLP-1 is one of the hormones involved in this process. Medicines that act on GLP-1 receptors can strengthen feelings of satiety, helping some people feel fuller after eating smaller portions.

This can make it easier to maintain a reduced-calorie eating pattern over time.

How Wegovy Works

Wegovy contains semaglutide, a GLP-1 receptor agonist.

It works by mimicking the action of GLP-1, helping reduce hunger and increasing feelings of fullness after eating.

Treatment usually follows a gradual dose-escalation schedule rather than starting immediately at the highest dose. This allows the body time to adjust and may improve tolerability.

Wegovy is intended to be used alongside lifestyle changes rather than replacing them.

How Mounjaro Works

Mounjaro contains tirzepatide.

Unlike semaglutide, tirzepatide acts on two hormonal pathways: GLP-1 and GIP. These hormones are involved in appetite regulation and metabolic control.

This dual mechanism is one reason Mounjaro has received considerable attention in weight management.

However, popularity does not mean that it is automatically the right treatment for every person. Clinical suitability still depends on medical history, current medicines and other individual factors.

What Makes Modern Injections Different?

Traditional weight loss approaches often focus heavily on reducing calorie intake.

Modern prescription injections can also influence the physiological signals that affect hunger and fullness.

For some patients, reducing persistent hunger may make healthier food choices and portion control easier to maintain.

The NHS explains that weight management medicines are used alongside dietary changes and physical activity, rather than replacing healthier lifestyle habits.

Common Side Effects

Digestive side effects are among the most frequently reported with GLP-1 and related medicines.

Possible symptoms include:

• Nausea
• Vomiting
• Constipation
• Diarrhoea
• Indigestion
• Abdominal discomfort

These effects can sometimes become more noticeable when treatment begins or following a dose increase.

Smaller meals, slower eating and adequate hydration may help some people manage mild symptoms.

Weight Loss Medicines Are Not Stand-Alone Solutions

Medication can make appetite easier to manage, but long-term weight management still depends on wider lifestyle habits.

Nutrition quality, physical activity, sleep and stress can all influence weight and health.

Resistance exercise and adequate protein intake may also be useful for supporting muscle mass during weight loss.

Developing these habits while using treatment can help create a more sustainable approach.

What Happens When Treatment Stops?

One of the important questions surrounding weight loss medication is what happens after treatment ends.

Appetite may increase when the effects of the medicine are no longer present. This can make weight maintenance more challenging.

For this reason, lifestyle habits developed during treatment remain important even after medication is reduced or discontinued.

Long-term weight management may involve ongoing nutritional, behavioural and clinical support.